UNSPSC 85815316: Introduction of liquid brachytherapy radioisotope into respiratory tract, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of liquid brachytherapy radioisotope into respiratory tract, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0F304

UNSPSC 85815316 Introduction of liquid brachytherapy radioisotope into respiratory tract, percutaneous approach is a Commodity code with minimal alignment to recent state and local procurement activity. The code describes a narrow medical procedure involving radioisotope injection, yet the opportunities tagged under this classification span broad healthcare service categories—virtual urgent care, medical services, PACE operations, cancer registry services, occupational health, behavioral health, jail medical staffing, wellness programs, and opioid treatment initiatives—none of which directly correspond to brachytherapy or radioisotope introduction. The recent opportunities show no solicitation for brachytherapy services, radioisotope procurement, or related interventional radiology work.

State and local issuing bodies across California, Georgia, Nevada, Colorado, Florida, Kansas, Arizona, Texas, and others are actively procuring behavioral health, occupational health, emergency medical services, cancer screening, and integrated care programs under this code tag, but the tagging appears to be a data quality issue rather than genuine procurement activity aligned with the code's nominal scope. The mismatch between code definition and actual buying patterns signals that this Commodity code shows little relevant recent activity for business development purposes focused on brachytherapy or radioisotope services delivery to state and local health systems.